Category Archives: Psychiatry/Neurology

Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance.

Posted on January 16, 2013 by Maurice Preter MD

Arch Neurol. 2012 Feb;69(2):183-90. doi: 10.1001/archneurol.2011.1426. Epub 2011 Oct 10. Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Health, keto, Psychiatry/Neurology | Tagged demyelinating disease, Inflammation, keto |

Modifiable factors influencing relapses and disability in multiple sclerosis.

Posted on January 16, 2013 by Maurice Preter MD

Mult Scler. 2010 Jul;16(7):773-85. doi: 10.1177/1352458510367721. Epub 2010 May 18. Modifiable factors influencing relapses and disability in multiple sclerosis. D’hooghe MB, Nagels G, Bissay V, De Keyser J. Source National Center For Multiple Sclerosis, Melsbroek, Belgium. marie.dhooghe@ms-centrum.be Abstract A growing … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, Psychiatry/Neurology | Tagged demyelinating disease, Inflammation, informed consent, keto, Medication effects - wanted and unwanted |

Fingolimod treatment for multiple sclerosis patients What do we do with varicella?

Posted on January 16, 2013 by Maurice Preter MD

Fingolimod treatment for multiple sclerosis patie… [Ann Neurol. 2011] – PubMed – NCBI. Ann Neurol. 2011 Oct;70(4):673-4; author reply 674. doi: 10.1002/ana.22605. Fingolimod treatment for multiple sclerosis patients What do we do with varicella? Winkelmann A, Loebermann M, Reisinger EC, … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, keto, new treatments, Psychiatry/Neurology | Tagged demyelinating disease, Inflammation, informed consent, keto, Medication effects - wanted and unwanted |

Melanoma occurring during treatment with fingo… [Arch Dermatol. 2011] – PubMed – NCBI

Posted on January 16, 2013 by Maurice Preter MD

Arch Dermatol. 2011 Aug;147(8):991-2. doi: 10.1001/archdermatol.2011.212. Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report. Conzett KB, Kolm I, Jelcic I, Kamarachev J, Dummer R, Braun R, French LE, Linnebank M, Hofbauer GF. PMID: 21844470 [PubMed – … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, new treatments, Psychiatry/Neurology | Tagged demyelinating disease, Inflammation, informed consent, keto, long-term effects |

Delayed fingolimod-associated asystole. [Mult Scler. 2011] – PubMed – NCBI

Posted on January 16, 2013 by Maurice Preter MD

Mult Scler. 2011 Nov;17(11):1387-9. doi: 10.1177/1352458511410344. Epub 2011 Jun 7. Delayed fingolimod-associated asystole. Espinosa PS, Berger JR. Source North Oaks Neurology, Hammond, LA, USA. ps.espinosa@gmail.com Abstract Oral fingolimod (Gilenya) is a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, keto, new treatments, Psychiatry/Neurology | Tagged demyelinating disease, Inflammation, keto |

Category Archives: Psychiatry/Neurology

Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance.

Delayed fingolimod-associated asystole. [Mult Scler. 2011] – PubMed – NCBI

Maurice Preter, MD

QUICK LINKS

ADDRESS